Ospedale Infermi di Rimini
- Address
- Ospedale Infermi Viale Settembrini 2, 47900 Rimini, Italy
Ospedale Infermi di Rimini - Multi-Specialty Clinical Research Center
Ospedale Infermi di Rimini is a comprehensive clinical research center engaged in diverse therapeutic areas ranging from oncology to cardiovascular and renal diseases. The facility demonstrates particular strength in precision medicine approaches and targeted therapy strategies, conducting innovative trials that aim to optimize treatment based on molecular profiling and individual patient characteristics.
- Advanced oncology trials in non-small cell lung cancer and recurrent ovarian cancer, focusing on targeted therapies and biomarker-driven treatment approaches
- Cardiovascular research investigating novel antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention
- Nephrology studies evaluating targeted therapies for IgA nephropathy based on kidney biopsy findings
- Infectious disease research including adaptive platform trials for community-acquired pneumonia and respiratory tract infections
The center's research portfolio reflects a commitment to personalized medicine, with multiple trials incorporating molecular diagnostics, genetic profiling, and histopathological assessment to guide therapeutic decisions. This approach is evident across their oncology programs, which focus on MET pathway alterations and BRCA status, as well as their renal disease studies utilizing biopsy-guided treatment selection. Ospedale Infermi di Rimini participates in both national collaborative networks and international platform trials, contributing to evidence-based advances in patient care across multiple medical disciplines.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 7 therapeutic areas and 15 of 45 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1AGO Research GmbH1active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale Infermi di Rimini
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter Randomized Controlled Trial Comparing Short-Course Amoxicillin/Clavulanic Acid After Fever Resolution to Standard 10-Day Regimen for Febrile Urinary Tract Infections in Children | Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 45 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bevacizumab | 2 | Unknown | 2022-08-31 | 2024-12-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.